Health
CRISPR-Cas9 Editing Can Favor Cancer-Linked KRAS Genes – Clinical OMICs News
Clinical trials based on CRISPR technology have been deferred due to potential risks, such as off-target effects, the creation…
Highlighting the need to monitor patients who have undergone CRISPR-Cas9-based gene therapy for cancer-related mutations, researchers at Sanford Burnham Prebys have shown that gene editing, specifically gene knockout (KO) using CRISPR-Cas9 technology, can…
Continue Reading
-
Noosa News18 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News24 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business23 hours agoAre BHP shares are buy after its results?
-
Business13 hours agoprofit up 7%, guidance strong